Autoimmune Hemolytic Anemia

Not yet recruiting

Study Name: A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA)
Condition: Anemia, Hemolytic, Autoimmune
Date: 2017-03-03
Interventions: Drug: SYNT001 IV in 250 mL over 1 hour administered on Day 0, 7, 14, 21, and 28

Recruiting

Study Name: Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Date: 2016-06-23
Interventions: Biological: blood sample

Completed

Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Condition: Cold Agglutinin Disease Autoimmune Hemolytic Anemia
Date: 2016-02-16
Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab

Recruiting

Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Date: 2015-11-19
Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti

Recruiting

Study Name: Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Condition: Bullous Pemphigoid (BP) Cold Agglutinin Disease Warm
Date: 2015-07-07
Interventions: Drug: TNT009 Other: Placebo

Not yet recruiting

Study Name: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Condition: Autoimmune Hemolytic Anemia
Date: 2015-02-13
Interventions: Drug: Interleukine-2 Four courses of IL2 ( [Proleukin, Nov

Recruiting

Study Name: Immunopathology of Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Date: 2014-03-05
Interventions: Biological: blood samples

Not yet recruiting

Study Name: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
Condition: Anemia Anemia, Hemolytic Anemia, Hemolytic, Autoimmune
Date: 2012-04-13
Interventions: Drug: levamisole

Completed

Study Name: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Date: 2011-04-28
Interventions: Drug: prednisone, low dose rituximab Patients with "w

Active, not recruiting

Study Name: Rituximab in Auto-Immune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia
Date: 2010-08-12
Interventions: Drug: rituximab (Mabthera®)

A Network Connecting Healthcare Professionals
WebHealthNetwork Membership: 2,384,339

sign up

log in

Autoimmune Hemolytic Anemia - 16 Studies Found

Status	Study
Not yet recruiting	Study Name: A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) Condition: Anemia, Hemolytic, Autoimmune Date: 2017-03-03 Interventions: Drug: SYNT001 IV in 250 mL over 1 hour administered on Day 0, 7, 14, 21, and 28
Recruiting	Study Name: Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2016-06-23 Interventions: Biological: blood sample
Completed	Study Name: Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease Condition: Cold Agglutinin Disease Autoimmune Hemolytic Anemia Date: 2016-02-16 Interventions: Drug: Bendamustine, Rituximab Bendamustine, Rituximab
Recruiting	Study Name: A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA) Condition: Warm Antibody Autoimmune Hemolytic Anemia Date: 2015-11-19 Interventions: Drug: Fostamatinib 150 mg bid Fostamatinib 150 mg bid. The dose of Fostamatinib may be reduced at any ti
Recruiting	Study Name: Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders Condition: Bullous Pemphigoid (BP) Cold Agglutinin Disease Warm Date: 2015-07-07 Interventions: Drug: TNT009 Other: Placebo
Not yet recruiting	Study Name: Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment Condition: Autoimmune Hemolytic Anemia Date: 2015-02-13 Interventions: Drug: Interleukine-2 Four courses of IL2 ( [Proleukin, Nov
Recruiting	Study Name: Immunopathology of Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Anemia Date: 2014-03-05 Interventions: Biological: blood samples
Not yet recruiting	Study Name: Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. Condition: Anemia Anemia, Hemolytic Anemia, Hemolytic, Autoimmune Date: 2012-04-13 Interventions: Drug: levamisole
Completed	Study Name: A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type) Date: 2011-04-28 Interventions: Drug: prednisone, low dose rituximab Patients with "w
Active, not recruiting	Study Name: Rituximab in Auto-Immune Hemolytic Anemia Condition: Warm Autoimmune Hemolytic Anemia Date: 2010-08-12 Interventions: Drug: rituximab (Mabthera®)